tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TXMD Stock Latest News

TherapeuticsMD Reports Improved Q2 2025 Results
Company AnnouncementsTherapeuticsMD Reports Improved Q2 2025 Results
18d ago
TXMD
TherapeuticsMD Reports Q2 2025 Financial Results
PremiumCompany Announcements
TherapeuticsMD Reports Q2 2025 Financial Results
28d ago
8K
TXMD
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
PremiumThe Fly
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
28d ago
TXMD
TherapeuticsMD Reports Improved Q1 2025 Results
PremiumCompany Announcements
TherapeuticsMD Reports Improved Q1 2025 Results
4M ago
TXMD
TherapeuticsMD Reports Q1 2025 Financial Results
PremiumCompany Announcements
TherapeuticsMD Reports Q1 2025 Financial Results
4M ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
PremiumThe FlyTherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
4M ago
TXMD
TherapeuticsMD Reports Improved Financial Performance
Premium
Company Announcements
TherapeuticsMD Reports Improved Financial Performance
5M ago
TXMD
TherapeuticsMD Reports Reduced Losses and Revenue Growth
Premium
Company Announcements
TherapeuticsMD Reports Reduced Losses and Revenue Growth
6M ago
8K
TXMD
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
10M ago
TXMD
TherapeuticsMD Shifts Focus with Lower Q3 Losses
PremiumCompany Announcements
TherapeuticsMD Shifts Focus with Lower Q3 Losses
10M ago
8K
TXMD
TherapeuticsMD Releases Preliminary Quarterly Financial Results
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Quarterly Financial Results
1y ago
8K
TXMD
TherapeuticsMD Releases Preliminary Q1 2024 Financials
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Q1 2024 Financials
1y ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
PremiumThe FlyTherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
1y ago
TXMD
TherapeuticsMD Announces 2023 Annual Financial Results
Premium
Company Announcements
TherapeuticsMD Announces 2023 Annual Financial Results
1y ago
8K
TXMD
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
Premium
The Fly
60 Degrees Pharmaceuticals appoints Kristen Landon as CCO
2y ago
SXTP
TXMD
Knight Therapeutics announces launch for IMVEXXY in Canada
PremiumThe Fly
Knight Therapeutics announces launch for IMVEXXY in Canada
2y ago
TXMD
Therapeuticsmd Inc (TXMD) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Therapeuticsmd Inc (TXMD) Q3 Earnings Cheat Sheet
2y ago
TXMD
TherapeuticsMD reports Q2 EPS (24c) vs. ($1.70) last year
PremiumThe Fly
TherapeuticsMD reports Q2 EPS (24c) vs. ($1.70) last year
2y ago
TXMD
TherapeuticsMD reinstated with a Neutral at Cantor Fitzgerald
PremiumThe Fly
TherapeuticsMD reinstated with a Neutral at Cantor Fitzgerald
3y ago
TXMD
TherapeuticsMD Inks Licensing Deal with Mayne Pharma
PremiumMarket NewsTherapeuticsMD Inks Licensing Deal with Mayne Pharma
3y ago
TXMD
TherapeuticsMD enters agreements to license products to Mayne Pharma
Premium
The Fly
TherapeuticsMD enters agreements to license products to Mayne Pharma
3y ago
TXMD
TherapeuticsMD reports Q3 EPS ($3.13) vs. ($5.62) a year ago
Premium
The Fly
TherapeuticsMD reports Q3 EPS ($3.13) vs. ($5.62) a year ago
3y ago
TXMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >